Rheinmetall's Order Pipeline Keeps Flowing, Even as the Bull-Bear Divide Widens
Published on 08/17/2026 at 20:42 | Redaktion boerse-global.de
The defense contractor's inbox is filling up faster than its analysts can agree on what it all means. Rheinmetall has spent the past week stacking up contract announcements across two continents — from autonomous supply vehicles for the US Army to a major expansion of its medical equipment business with the Bundeswehr — while Wall Street and Frankfurt-based research houses have staked out sharply divergent views on where the stock goes from here.
Shares were changing hands at €1,221.20 in recent trading, up 1.2 percent on the day, though that masks a more volatile backdrop. The stock has climbed 6.1 percent over seven trading sessions and sits 34 percent above its June low of €902.50, yet remains 40 percent below its October peak of €2,007.00.
Bundeswehr Expands Field Hospital Fleet
The latest piece of news came from the group's medical division. Rheinmetall Project Solutions GmbH has called down an extension of the "Modular Sanitary Facilities" (MSE) program, pushing the total contract value past €600 million gross. The framework agreement, originally signed with the Bundeswehr at the end of 2024, now covers 165 systems, with production slated to begin in the first quarter of 2027.
The bulk of the expansion — more than €500 million gross — covers 149 mobile rescue stations in both protected and unprotected configurations. It's the kind of recurring, framework-based business that gives the group's order book a steady hum, complementing its larger land-systems franchise.
Managing complex operations like these comes with its own set of workplace risks — and documenting them properly is a legal duty many employers get wrong. A free toolkit with 41 ready-to-use templates and checklists helps you stay compliant without the paperwork headache. Download the free Risk Assessment Toolkit
US Army Taps Rheinmetall for Autonomous Logistics
Across the Atlantic, American Rheinmetall has picked up an 18-month development and deployment contract under the US Army's Project Sustainment program for autonomous unmanned ground vehicles. The vehicles are designed to handle tactical resupply missions, with production expected to start in 2027 and initial revenues following in 2028. Harbinger will supply the vehicle technology, while Forterra handles the autonomous onboard systems.
The award extends a string of US-focused wins for the subsidiary and underscores Rheinmetall's push to gain a firmer foothold in the American defense market. CEO Armin Papperger, speaking to Reuters, also addressed the company's ATACMS rocket production partnership with Lockheed Martin, noting that ramping up manufacturing will take time — particularly given that US weapons stockpiles have been depleted amid the Iran conflict. The production facility in Unterlüß is scheduled to be built in 2027, with first revenues expected in 2028.
Papperger also reiterated interest in Leonardo's Iveco military vehicle division, though he signaled that depends on the direction taken by Lorenzo Mariani, the new head of TKMS. The Bundeswehr's Boxer vehicle order, he added, should be signed by year-end.
A Tale of Two Ratings
The operational news flow has been predominantly positive, but the analyst community is clearly split on how to read the company's strategic direction. mwb research's Jens-Peter Rieck downgraded the stock from "Hold" to "Sell" over the weekend, cutting his price target from €1,150 to €1,050 on what he called an unfavorable risk-reward profile. His concerns center on Rheinmetall's halved investment ratio of 8 to 9 percent and the reduced backlog target, which the company trimmed from €135 billion to €100–120 billion. It's the third adjustment from Rieck in a matter of weeks — he had already moved the stock from "Buy" to "Neutral" following the NATO summit.
That bearish call stands in stark contrast to Goldman Sachs' Sam Burgess, who reaffirmed a "Buy" rating and €2,300 price target on the same day as the half-year results — implying substantial upside from current levels. The gap between those two targets, more than €1,200, illustrates just how differently the market is weighing the capital intensity of Rheinmetall's recent decisions.
Smaller Orders, Steady Demand
The contract flow hasn't been limited to the big-ticket items. In early August, the Danish armed forces placed an order for the MASS decoy system, valued in the double-digit millions, with deliveries starting in the fourth quarter of 2027 for the Absalon- and Iver Huitfeldt-class frigates. Rheinmetall also signed a long-term supply agreement with the Danish navy running up to 21 years.
These smaller but recurring orders help underpin the backlog, even if they don't settle the broader strategic debate. That debate was sharpened last Thursday when Rheinmetall cut its full-year revenue guidance to €13.7–14.2 billion following the loss of the F126 frigate project to rival TKMS. Deutsche Bank, however, characterized the guidance reduction as a pure timing shift in order intake and maintained its "Buy" rating with an €1,800 target.
When you're responsible for workplace safety, the stakes are just as high — and the paperwork can pile up fast. Over 37,000 UK businesses use a free toolkit with 43 customisable templates to meet their legal duties on hazardous substances. Get the free COSHH Toolkit
Other houses have also chimed in with constructive views. RBC Capital Markets initiated coverage with an "Outperform" rating and €1,600 price target, citing Rheinmetall's strong positioning in European defense programs and expected EBITA growth of 35 percent annually through 2030. Jefferies raised its target from €1,300 to €1,350 while keeping a "Buy" stance after adjusting models to the latest quarterly figures.
For investors, the immediate question is whether the steady stream of orders — from German field hospitals to Danish decoys to American drones — will eventually translate into free cash flow, which remained deeply negative in the first half. The order book is growing, but so is the debate about what it costs to build it.
